219 related articles for article (PubMed ID: 18836193)
41. An expanded model of replicating human immunodeficiency virus reverse transcriptase.
Wöhrl BM; Tantillo C; Arnold E; Le Grice SF
Biochemistry; 1995 Apr; 34(16):5343-56. PubMed ID: 7537089
[TBL] [Abstract][Full Text] [Related]
42. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
43. Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase.
Gopalakrishnan V; Benkovic S
J Biol Chem; 1994 Feb; 269(6):4110-5. PubMed ID: 7508439
[TBL] [Abstract][Full Text] [Related]
44. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
[TBL] [Abstract][Full Text] [Related]
45. RNase H sequence preferences influence antisense oligonucleotide efficiency.
Kielpinski LJ; Hagedorn PH; Lindow M; Vinther J
Nucleic Acids Res; 2017 Dec; 45(22):12932-12944. PubMed ID: 29126318
[TBL] [Abstract][Full Text] [Related]
46. Structural biochemistry of a type 2 RNase H: RNA primer recognition and removal during DNA replication.
Chapados BR; Chai Q; Hosfield DJ; Qiu J; Shen B; Tainer JA
J Mol Biol; 2001 Mar; 307(2):541-56. PubMed ID: 11254381
[TBL] [Abstract][Full Text] [Related]
47. Insights into RNA/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex.
Pallan PS; Egli M
Cell Cycle; 2008 Aug; 7(16):2562-9. PubMed ID: 18719385
[TBL] [Abstract][Full Text] [Related]
48. Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.
Tramontano E; Corona A; Menéndez-Arias L
Antiviral Res; 2019 Nov; 171():104613. PubMed ID: 31550450
[TBL] [Abstract][Full Text] [Related]
49. Reverse transcription of the Mauriceville plasmid of Neurospora. Lack of ribonuclease H activity associated with the reverse transcriptase and possible use of mitochondrial ribonuclease H.
Wang H; Lambowitz AM
J Biol Chem; 1993 Sep; 268(25):18951-9. PubMed ID: 7689563
[TBL] [Abstract][Full Text] [Related]
50. Acceptor RNA cleavage profile supports an invasion mechanism for HIV-1 minus strand transfer.
Chen Y; Balakrishnan M; Roques BP; Bambara RA
J Biol Chem; 2005 Apr; 280(15):14443-52. PubMed ID: 15657044
[TBL] [Abstract][Full Text] [Related]
51. Mutating conserved residues in the ribonuclease H domain of Ty3 reverse transcriptase affects specialized cleavage events.
Lener D; Budihas SR; Le Grice SF
J Biol Chem; 2002 Jul; 277(29):26486-95. PubMed ID: 11994277
[TBL] [Abstract][Full Text] [Related]
52. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
[TBL] [Abstract][Full Text] [Related]
53. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
[TBL] [Abstract][Full Text] [Related]
54. Dynamic NMR structures of [Rp]- and [Sp]-phosphorothioated DNA-RNA hybrids: is flexibility required for RNase H recognition?
Tonelli M; Ulyanov NB; Billeci TM; Karwowski B; Guga P; Stec WJ; James TL
Biophys J; 2003 Oct; 85(4):2525-38. PubMed ID: 14507715
[TBL] [Abstract][Full Text] [Related]
55. Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H.
Schultz SJ; Zhang M; Champoux JJ
J Biol Chem; 2006 Jan; 281(4):1943-55. PubMed ID: 16306040
[TBL] [Abstract][Full Text] [Related]
56. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
57. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
Driscoll MD; Golinelli MP; Hughes SH
J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
59. The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding.
Leo B; Schweimer K; Rösch P; Hartl MJ; Wöhrl BM
Retrovirology; 2012 Sep; 9():73. PubMed ID: 22962864
[TBL] [Abstract][Full Text] [Related]
60. Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.
Smith JS; Gritsman K; Roth MJ
J Virol; 1994 Sep; 68(9):5721-9. PubMed ID: 7520094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
